Menally-Ill
02-27-2003, 11:01 PM
Prison-based syringe exchange programmes: a review of international
research and development.
Addiction. 2003 Feb; 98(2): 153-8
Dolan, K; Rutter, S; Wodak, A D
Journal publications and conference presentations on prison-based syringe exchange (PSE) programmes were identified by a comprehensive search of electronic databases. Experts involved with development and evaluation of current PSE programmes or policy were contacted for reports, documents
and unpublished material. Spanish information on PSE was translated for this review.
We identified 14 papers specifically on PSE programmes in Switzerland (six papers), Germany (four) and Spain (four). The first PSE programme started in 1992 in Switzerland. As of December 2000, seven PSEs were operating in Switzerland, seven in Germany and five in Spain. There have been six evaluations of prison syringe exchange programmes and all have been favourable.
Reports of drug use decreased or remained stable over time. Reports of syringe sharing declined dramatically. No new cases of HIV, hepatitis B or hepatitis C transmission were reported. The evaluations found no reports of serious unintended negative events, such as initiation of injection or
of the use of needles as weapons. Staff attitudes were generally positive but response rates to these surveys varied.
Overall, this review indicated that prison syringe exchange
programmes are feasible and do provide benefit in the reduction of risk behaviour and the transmission of blood-borne infection without any unintended negative consequences.
research and development.
Addiction. 2003 Feb; 98(2): 153-8
Dolan, K; Rutter, S; Wodak, A D
Journal publications and conference presentations on prison-based syringe exchange (PSE) programmes were identified by a comprehensive search of electronic databases. Experts involved with development and evaluation of current PSE programmes or policy were contacted for reports, documents
and unpublished material. Spanish information on PSE was translated for this review.
We identified 14 papers specifically on PSE programmes in Switzerland (six papers), Germany (four) and Spain (four). The first PSE programme started in 1992 in Switzerland. As of December 2000, seven PSEs were operating in Switzerland, seven in Germany and five in Spain. There have been six evaluations of prison syringe exchange programmes and all have been favourable.
Reports of drug use decreased or remained stable over time. Reports of syringe sharing declined dramatically. No new cases of HIV, hepatitis B or hepatitis C transmission were reported. The evaluations found no reports of serious unintended negative events, such as initiation of injection or
of the use of needles as weapons. Staff attitudes were generally positive but response rates to these surveys varied.
Overall, this review indicated that prison syringe exchange
programmes are feasible and do provide benefit in the reduction of risk behaviour and the transmission of blood-borne infection without any unintended negative consequences.